Ramana Doppalapudi, PhDVice President, Chemistry at Avidity BiosciencesSpeaker
Profile
Dr. Ramana Doppalapudi is a seasoned scientist with broad expertise in the discovery and development of diverse therapeutic modalities, including peptides, antibodies, oligonucleotides, and antibody-drug conjugates. He has a strong track record of leadership across pharmaceutical companies of various sizes, consistently driving innovation and advancing multiple clinical candidates for the treatment of cancer, and muscular diseases. He is a key inventor of the pioneering AOCTM (Antibody Oligonucleotide Conjugate) technology and has a pivotal role in the advancement of notable drug candidates such as Del-desiran, Del-brax, and Del-zota. He is the author of more than 50 scientific publications and patents and currently serves as Vice President of Chemistry at Avidity Biosciences in La Jolla, California.
Agenda Sessions
Advancing Therapeutics with Antibody-Oligonucleotide Conjugates: Clinical Progress in Rare Muscle Diseases and Emerging Applications in Precision Cardiology
, 9:30amView Session